Evidence map›Paper›PMID 37085257›Full record

ArticleKidney international2023

Echocardiographic parameters and cardiovascular disease in Japanese- and US-based CKD cohorts.

Carl P Walther, Sankar D Navaneethan

Abstract readComparative StudyComment
PubMed Publisher
In one paragraph

Article in Kidney international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Carl P WaltherSection of Nephrology, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas, USA.
Sankar D NavaneethanSection of Nephrology, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas, USA; Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA; Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA. Electronic address: sankar.navaneethan@bcm.edu.

Funding

The kidney in advanced heart failure and durable mechanical circulatory support: phenotypes, prediction, and pathophysiologyK23DK122131 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI WALTHER, CARL · 2020 to 2024
$922k
MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASEK24HL161414 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Sankar Dass Navaneethan · 2022 to 2026
$588k
NHLBI NIH HHS K24 HL161414NIDDK NIH HHS K23 DK122131
6 · The paper itself

Abstract

Japanese and US populations have similar chronic kidney disease prevalence but differing clinical outcomes. A secondary analysis compared cardiovascular outcomes in a Japanese- and a US-based chronic kidney disease cohort and found that the US cohort had markedly worse cardiovascular outcomes. Mediation analysis demonstrated that differences in left ventricular structure and function could explain most of the cardiovascular outcome difference. We examine and contextualize this finding and describe implications for precision nephrology and for population health.

Indexed as

Cardiovascular DiseasesEchocardiographyHeart VentriclesRenal Insufficiency, ChronicCohort StudiesEast Asian PeopleHumansJapanUnited States

Identifiers

PMID37085257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.